The results above suggested that levels of activated (pY)-STAT3 were increased in dysplasia vs. normal colonic mucosa and that TTI-101 decreased adenomas by reducing the levels of pY-STAT3 in dysplastic mucosa. The gene discussed is STAT3; the disease is dysplasia.